Condition: Glomerulonephritis, IGA · Sponsor: Centre Hospitalier Universitaire de Besancon
This study aims to investigate the relevance of the Tfh/Tfr (Follicular helper T cells/ Follicular regulatory T cells) ratio in patients with IgA nephropathy: * To identify a differential expression of the Tfh/Tfr ratio in patients considered stable or progressive * To predict, at diagnosis, the clinical evolution of the disease (progressive or stable form) in the first year.
This description comes directly from the study's public registry record.
Charline Vauchy, PhD. · 0381218875 · cvauchy@chu-besancon.fr
Always discuss trial participation with your own doctor first.
| Centre Hospitalier Universitaire de Besançon | Besançon, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05791162